Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04798833Not ApplicableActive Not Recruiting

Newborn Care Kit to Save Lives in GB, Pakistan

Role: collaborator

NCT04581993Not ApplicableCompleted

Effectiveness of SNF and SBCC to Prevent Stunting Among Children in Afghanistan: a Quasi-experimental Study

Role: collaborator

NCT01487278Not ApplicableWithdrawn

Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in Mali

Role: collaborator

NCT00116480Not ApplicableCompleted

Misoprostol in the Treatment of Postpartum Hemorrhage

Role: collaborator

NCT00120237Not ApplicableCompleted

Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan

Role: collaborator

All 5 trials loaded